TrialScience advances2026

Multiomics profiling and experiments in preclinical models revealed RAD51-IN-1 as a synergistic potentiator of anlotinib sensitivity.

Huangyang Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.